| Product Code: ETC12838625 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Fiji continued to rely on key trading partners such as Australia, New Zealand, India, Bangladesh, and the USA for its influenza medications import shipments. Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) of 6.89% over the period 2020-2024 indicates a steady rise in demand for these medications. The high concentration of the Herfindahl-Hirschman Index (HHI) suggests a competitive market landscape, with opportunities for further market expansion and diversification in the future.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Influenza Medications Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Fiji Influenza Medications Market - Industry Life Cycle |
3.4 Fiji Influenza Medications Market - Porter's Five Forces |
3.5 Fiji Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Fiji Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Fiji Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Fiji Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in influenza outbreaks in Fiji |
4.2.2 Growing awareness about the importance of early treatment of influenza |
4.2.3 Rising healthcare expenditure in Fiji |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in rural areas of Fiji |
4.3.2 High cost of influenza medications |
4.3.3 Presence of counterfeit medications in the market |
5 Fiji Influenza Medications Market Trends |
6 Fiji Influenza Medications Market, By Types |
6.1 Fiji Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Fiji Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Fiji Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Fiji Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Fiji Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Fiji Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Fiji Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Fiji Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Fiji Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Fiji Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Fiji Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Fiji Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Fiji Influenza Medications Market Import-Export Trade Statistics |
7.1 Fiji Influenza Medications Market Export to Major Countries |
7.2 Fiji Influenza Medications Market Imports from Major Countries |
8 Fiji Influenza Medications Market Key Performance Indicators |
8.1 Number of reported influenza cases in Fiji |
8.2 Percentage of population vaccinated against influenza |
8.3 Number of healthcare facilities offering influenza medications and treatment |
8.4 Average time taken for patients to receive influenza treatment after diagnosis |
8.5 Rate of adherence to prescribed influenza medications |
9 Fiji Influenza Medications Market - Opportunity Assessment |
9.1 Fiji Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Fiji Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Fiji Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Fiji Influenza Medications Market - Competitive Landscape |
10.1 Fiji Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Fiji Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here